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Abstract: Lytic polysaccharide monooxygenases (LPMOs) 
are recently discovered copper enzymes that cleave 
recalcitrant polysaccharides by oxidation. The structure 
of an Aspergillus oryzae LPMO from the starch degrading 
family AA13 (AoAA13) has previously been determined 
from an orthorhombic crystal grown in the presence of 
copper, which is photoreduced in the structure. Here 
we describe how crystals reliably grown in presence 
of Zn can be Cu-loaded post crystallization. A partly 
photoreduced structure was obtained by severely limiting 
the X-ray dose, showing that this LPMO is much more 
prone to photoreduction than others. A serial synchrotron 
crystallography structure was also obtained, showing 
that this technique may be promising for further studies, 
to reduce even further photoreduction. We additionally 
present a triclinic structure of AoAA13, which has less 
occluded ligand binding site than the orthorhombic one. 
The availability of the triclinic crystals prompted new ligand 
binding studies, which lead us to the conclusion that small 
starch analogues do not bind to AoAA13 to an appreciable 
extent. A number of disordered conformations of the metal 
binding histidine brace have been encountered in this and 
other studies, and we have previously hypothesized that 
this disorder may be a consequence of loss of copper. We 
performed molecular dynamics in the absence of active 
site metal, and showed that the dynamics in solution 
differ somewhat from the disorder observed in the crystal, 
though the extent is equally dramatic.
Keywords: LPMO; starch degradation; photoreduction; 
substrate binding; molecular dynamics.
Abbreviations
AA, auxiliary activities; AnAA13, lytic polysaccharide 
monooxygenase from Aspergillus nidulans; AoAA13, lytic 
polysaccharide monooxygenase from Aspergillus oryzae; 
CAZy, Carbohydrate Active enZyme database; CBM, 
carbohydrate binding module; LPMO, lytic polysaccharide 
monooxygenase; MD, molecular dynamics; MoLPMO13A, 
lytic polysaccharide monooxygenase from Magnaporthe 
oryzae; NcAA13, lytic polysaccharide monooxygenase 
from Nerospora crassa; PDB, Protein Data Bank; PEG, 
polyethylene glycol; RMSD, root mean square deviation; 
SSX, serial synchrotron crystallography; TaAA9A, lytic 
polysaccharide monooxygenase from Thermoascus 
aurantiacus.
1  Introduction
Lytic polysaccharide monooxygenases (LPMOs) are 
enzymes capable of boosting the degradation of 
recalcitrant polysaccharides, such as cellulose, chitin and 
starch (as reviewed in, e.g., [1-3]). They are metalloenzymes 
which, utilizing a single copper ion active-site in 
conjunction with external electron donors and molecular 
oxygen or hydrogen peroxide as co-substrates, have been 
observed to cleave the glycosidic bond oxidatively [2,4]. 
LPMOs are classified as auxiliary activities (AA) in the 
Carbohydrate Active enZymes database (CAZy) [5] and are 
to date differentiated into seven families: AA9, AA10, AA11, 
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AA13, AA14, AA15 and AA16. AA14, AA15 and AA16 are all 
recently discovered [6-8], while the rest have been known 
for some time. Similar for all LPMOs is the active site, 
which consists of two histidines, one being the N-terminal 
residue. The two histidines form the so-called histidine 
brace that coordinates the active copper ion [9]. This study 
focuses on Aspergillus oryzae AA13 (AoAA13), which is part 
of the starch degrading family. This family has not received 
as much attention as the chitinolytic/cellulolytic AA9-AA11 
families. The AA13 family was first described in Harris 
and Wogulis [10] as a family of polypeptides enhancing 
starch degradation, but it was not recognised as an LPMO 
until Vu et al. [11] described the activity of an AA13 from 
Neurospora crassa (NcAA13). In 2015 the first structure of 
an AA13 family member was determined [12]. The structure 
was of AoAA13 (from Aspergillus oryzae). No activity could 
be detected for AoAA13 but the synergetic activity of the 
highly related Aspergillus nidulans AA13 (AnAA13) with 
β-amylase on retrograded corn starch could be shown [12].
AnAA13 and AoAA13 are very similar in sequence 
(72% identity) and presumably structure, but AnAA13 is 
also associated with a family 20 carbohydrate binding 
module (CBM20). CBM20 is a family of starch-specific 
binding modules associated with many starch degrading 
enzymes including amylases, and most often C-terminally 
positioned with respect to the catalytic domains [13], 
and they are present in approximately 60% of all AA13 
sequences known to date. The first quantitative data of 
binding affinity for an AA13 enzyme containing CBM20 
was published by Nekiunaite et al. [14]. The binding 
affinity for Magnaporthe oryzae LPMO13A (MoLPMO13A) 
on insoluble wheat starch granules and Aspergillus 
terreus LPMO13A (AtLPMO13A) on β-cyclodextrin was 
comparable to CBM20-containing hydrolases, suggesting a 
very similar function and structure/function relationship 
for CBM20 in both hydrolytic and oxidative enzymes, 
namely to aid catalysis by increasing proximity to the 
substrate. Accordingly, the relationship among CBM20 
sequences followed taxonomy rather than whether they 
were appended to hydrolytic or oxidative enzymes [14]. 
AoAA13 possible ability to bind starch related substrates 
was further investigated by Frandsen et al. [15], who 
published ligand-bound crystal structures, however, they 
had uncertain biological relevance.
The active site of the AoAA13 consists of a copper ion 
coordinated by the histidine brace with an additional 
tyrosine as a more distant axial ligand. The catalytically 
crucial N-terminal histidine is methylated as is often 
observed for fungal LPMOs, but the purpose for this 
methylation is still unknown though some experiments 
with Thermoascus aurantiacus AA9A (TaAA9A) indicate 
it may protect the enzyme from oxidative damage [16]. 
According to current proposals of LPMO action, in the 
resting state of the enzyme the copper is in a copper(II) 
state and can coordinate to up to six ligands in a more 
or less distorted octahedral coordination, depending on 
the enzyme [2]. In this state the AoAA13 is presumably 
coordinated twice to the methylated histidine (MeHis1) 
once each to His91 and Tyr224 and two water molecules. 
Due to photoreduction in the X-ray beam, the copper 
in LPMOs is often reduced to copper(I) during the data 
collection, and therefore it expels the exogenous ligands 
to end up in a T-shape coordination as observed in the 
crystal structure of AoAA13 [2,12].
In all structures of AoAA13 so far, the active-site 
copper is either reduced to Cu(I) or substituted by Zn. Here 
we attempt to obtain a crystal structure in the resting state 
for AoAA13. Crystals produced for this study are in the 
previously described P212121 crystal form [12] grown in the 
presence of Zn. Since crystals cannot be reliably obtained 
in the presence of Cu, a robust procedure for exchanging 
the metal had to be developed first. As carefully reducing 
the X-ray dose and using helical data collection did not 
lead to a predominantly Cu(II) structure, we tested the 
possibility of using serial synchrotron crystallography 
(SSX) to reduce the effect of radiation [17], which seems to 
be promising for further studies.
Furthermore, we present a new P1 crystal form 
of AoAA13, which has a much more open putative 
substrate binding site. Unfortunately, attempts to obtain 
oligosaccharide complexes with this new crystal form were 
not successful. In fact, there is so far to our knowledge no 
direct evidence that AA13 domains bind oligosaccharides.
During crystallographic studies of AoAA13 presented 
here and previously we have encountered remarkable 
plasticity of the active site, which has been found in a 
number of conformations, for example while searching 
for oligosaccharide binding, a structure with an AoAA13 
was determined where one of the active-site histidines 
is ‘flipped’ completely out of its normal metal binding 
position [15]. We have therefore additionally explored 
the active site of AoAA13 by molecular dynamics (MD) 
simulations.
2  Materials and method
2.1  Crystallization and metal exchange
A batch of the endoH deglycosylated AoAA13 enzyme was 
produced as in previous studies (provided by Novozymes 
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A/S) and stored in 20 mM MES pH 6.0 and 125 mM NaCl at 
4 °C [10,12].
The crystals used for the low X-ray dose studies 
were grown in conditions based on previously reported 
crystallization [12] using the hanging drop vapour 
diffusion method with a reservoir consisting of 0.1 M 
buffer II pH 5.0 (0.2 M L-malic acid, 0.4 M MES, 0.4 M Tris) 
[18], 0.2 M Zn-acetate and 19-23% polyethylene glycol 
(PEG) 3000. The 4 µL hanging drop was set up by hand in 
a VDX plate (Hampton Research) and contained protein 
solution (6 mg/mL) and reservoir in a 3:1 ratio. The crystals 
were grown to full size in 3 days at room temperature. The 
crystals were then transferred in fibre loops to a soaking 
drop containing 22.5% (w/v) PEG 3000, 0.09 M buffer (II) 
pH 5.0, 0.5 mM Cu-acetate and 1 mg/mL bovine serum 
albumin. A few small crystals were transferred to satiate 
the solution before the crystals intended for data collection 
were transferred. The crystals were soaked for 10 min and 
mounted on fibre loops to be frozen in liquid nitrogen. No 
cryoprotectant was needed for the crystal. The method 
was quite tolerant of small variations in soaking times and 
concentrations of components.
Crystals used for SSX were grown using the same 
procedure as above. Crystals intended for the SSX 
experiment were grown to a size of 25 µm in each 
dimension. Crystals were harvested using mesh LithoLoops 
(Molecular Dimensions). Before flash freezing, a paper 
wick (MiTeGen) was taken to the underside of the mesh 
LithoLoop in order to remove excess liquid and allow the 
crystals to adhere to the surface of the mesh LithoLoop.
The protein stock solution of the glycosylated form 
of AoAA13 (in 20 mM Tris, 50 mM NaCl at pH 9.0) was 
concentrated to 24 mg/mL. Crystalline plates were 
obtained in a PACT screen (B12 condition: 0.01 M ZnCl2, 
20% (w/v) PEG 6000, 0.1 M MES, pH 6.0) [19] using the 
sitting drop vapour diffusion method in a MRC 2-drop 
plate (Molecular Dimensions) set up by an Oryx8 robot 
(Douglas Instruments). The crystals were reproducible 
with seeding in 14-20% (w/v) PEG 6000 with 17-24 mg/
mL protein in VDX plates using the hanging drop vapour 
diffusion method (1000 µL reservoir, 4 µL drop size, and 
1:1 ratio of protein:reservoir). The crystal used for structure 
determination was grown with 0.01 M ZnCl2, 14% (w/v) 
PEG 6000, 0.1 M MES, pH 6.0, and 30% (v/v) glycerol was 
used as cryoprotectant for flash freezing in a cryo-loop.
Later, the same crystal form (isomorphous and 
with similar plate morphology) was obtained under the 
standard conditions for the deglycosylated protein as 
stated above, by adding 15 µL Milli-Q water to a drop with 
already obtained crystals (this procedure was carried 
out in an attempt to obtain bigger crystals). The crystals 
dissolved due to the decrease in protein concentration 
and recrystallized in a few days with a very slight increase 
in size but also with formation of crystals of different 
morphology (plates). The reference plate crystals were 
mounted on fibre loops for data collection without 
Cu-acetate soak.
2.2  Oligosaccharide crystal soaks
Both metal-exchanged P212121 crystals and P1 plate crystals 
obtained during the recrystallization experiment were 
used for oligosaccharide soaking. To the regular Cu-acetate 
soak a final concentration of 500 mM maltose or 50 mM 
maltopentaose was added for the P212121 crystals and they 
were soaked for at least 10 minutes. For the plate crystals 
(P1) either 50 mM maltopentaose or 50 mM β-cyclodextrin 
were added to the regular Cu-acetate soak and the crystals 
were soaked for at least 10 minutes. No cryoprotectant was 
needed prior to flash freezing in cryo-loops.
2.3  Data collection and processing
All data were collected at cryotemperature (100 K). The 
lowest dose data were collected on ID23-1 [20] beamline 
at the ESRF using reduced transmission and helical data 
collection [21]. The crystal was rotated 100° in steps of 
0.1° while translating 45.5 µm along the crystal. Later, 
data from the same crystal were obtained on P11 at Petra 
III (DESY) [22] from collection at wavelengths of 1.00 Å 
and 1.35 Å for verification of the metal exchange. Data on 
a reference crystal were collected on ID23-1 at ESRF. The 
data were processed using the XDS program [23]. The 
average diffraction weighted dose for these and the SSX 
data below was calculated using Raddose3D [24].
SSX data sets were collected at beamline ID29 [25] 
at the ESRF using the mesh and collect routine [26]. Data 
were collected with a wavelength of 0.98 Å over 10° of 
total rotation with an oscillation of 0.1° per image at each 
of the crystals identified using the routine. The data sets 
were processed individually with identical parameters 
using XDS [23], using the first processable data set as a 
reference. The hierarchical cluster analysis software 
ccCluster [27] was initially used to determine, which data 
sets could be merged based on their pairwise correlation 
coefficient. It was, however, found that processing 
statistics were suboptimal after scaling using XSCALE 
[23]. We chose to merge all processable data sets and scale 
together. Data sets with an R-factor in the innermost shell 
above 20% were excluded from the scaling. All data sets 
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mentioned above (conventional data collection and SSX) 
belonged to the space group P212121, in which the structure 
was originally solved.
X-ray crystallographic data of the glycosylated form of 
AoAA13 were collected at I911-2 at the MAX-IV synchrotron 
in Lund, Sweden. The data could be processed in P1 with 
two molecules in the asymmetric units. Plate crystals of 
deglycosylated AoAA13 grown by recrystallization and 
used for oligosaccharide soaks were isomorphous to the 
P1 crystals of the glycosylated form. Data presented for 
the recrystallized P1 crystals were collected at ID23-1 at 
ESRF. Other crystal tests for this project were carried out 
at P11, Desy, Hamburg, ESRF beamlines or MAX IV Biomax 
beamline.
Data collection statistics are presented in Table 1 
for deposited structures (lowest dose AoAA13 Cu-bound 
structure, P1 glycosylated AoAA13 structure and SSX 
AoAA13 Zn-bound structure) and Table S1 (other collected 
data).
2.4  Structure determination, refinement and 
validation
The CCP4 suite was used for structure determination and 
refinement [28]. Structures of metal exchanged AoAA13 
crystals (and corresponding reference crystal) as well as 
low X-ray dose structures and SSX structure were phased by 
difference Fourier methods. The first glycosylated AoAA13 
structure in P1 was phased by Molecular Replacement in 
Molrep [29] with the preliminary AoAA13 structure used 
for phasing in [12] as search model. Oligosaccharide soaks 
in isomorphous crystals were subsequently phased by 
difference Fourier methods. All structures were refined in 
REFMAC5 [30] alternated with cycles of manual rebuilding 
in Wincoot [31].
We chose to deposit only structures, which gave 
new information compared to others in the Protein Data 
Bank (PDB), namely the lowest dose AoAA13 Cu-bound 
structure, P1 glycosylated AoAA13 structure and SSX 
AoAA13 Zn-bound structure. For the deposited structures, 
refinement and validation statistics and PDB deposition 
codes are in Table 1. For other structures that have been 
partly or fully refined, refinement and validation statistics 
are in Table S1.
2.5  Thermal shift assay
A thermal shift assay was conducted using a Tycho NT.6 
nano differential scanning fluorimetry instrument. 
To the AoAA13 sample copper acetate was added in 
stoichiometric amounts compared to the LPMO. Several 
potential ligands were tested to see if they would 
cause a shift in inflection temperature, which could 
indicate binding in solution. Maltose, maltopentaose, 
maltoheptaose and β-cyclodextrin (Sigma-Aldrich) as 
well as isomaltotriose, 63-α-d-glucosyl-maltotriose, and 
63-α-d-glucosyl-maltotriosyl-maltotriose (Megazymes) 
were dissolved separately in the same buffer as the protein 
(stated in section 2.1). AoAA13 and the oligosaccharide 
solutions were mixed to obtain final concentrations of 0.2 
mg/mL enzyme and 30-50 mM oligosaccharide and tested 
on the nano differential scanning fluorimetry instrument.
2.6  MD simulations
The MD simulations were performed in GROMACS 2016 
[32] with the CHARMM36 force field [33]. The PDB file 
(code: 4OPB) was stripped of ions (including the active 
site copper ion), ligands and water molecules and 
inserted into a cubic box (7.46 nm in each direction from 
the centre of the protein molecule). As GROMACS did 
not have an entry for the methylated histidine, a normal 
histidine was used instead in the N-terminal position. 
12871 SPC/E modelled water molecules were added to the 
box and the Genion subprogram in GROMACS was used 
to identify the charge of the protein and 20 Na+ ions were 
added to stabilize this charge. To avoid steric clashes, the 
system was relaxed by energy minimization using the 
steep minimization algorithm with a maximum of 50000 
steps and termination when maximum force obtained 
a value below 1000 kJ/mol/nm. Afterwards, the system 
was equilibrated in NVT equilibration at 300 K using 
Berendsen thermostat and NPT equilibration using 300 
K and 1.0 bar. Four simulations were run in total, two 
simulations of 10 ns (see Figure S2) and two of 40 ns, all 
using 1 fs timesteps with identical parameters, except for 
deviating thermal noise obtained by a random number 
generator.
Results of the MD simulations were analysed using 
GROMACS subprograms rmsf and rmsdist to calculate 
the deviation per residue over an entire simulation, and 
the average deviation of the whole protein molecule 
throughout the simulation, respectively. Additionally, the 
Python library Biopython [34] was used to extract the root 
mean square deviation (RMSD) at each time point of the 
simulation (only 10 ns to 40 ns considered) of His1 and 
His91 against published structures 4OPB and 5T7K, and 
the SSX structure from this study.
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3  Results
3.1  Active-site metal exchange
For AoAA13 no reliable crystallization procedure in 
the presence of copper ions has been established. The 
structure of AoAA13 with copper at the active site has 
been obtained through seeding, but the procedure was 
not deemed reproducible [12]. It is, however, possible to 
reliably crystallize the enzyme in the presence of zinc-
acetate solution and thereby have zinc at the active site 
[15]. In this paper we demonstrate that due to the high 
copper affinity in the active site, a soak containing copper 
acetate can successfully exchange the zinc ion at the active 
site for a copper ion in AoAA13. The metal ion exchange 
has been done in similar fashion for AoAA11 [35]. In this 
Table 1: Data collection, processing and refinement statistics for deposited structure.a
Low dose CuAoAA13 SSX AoAA13 (Zn) Glycosylated AoAA13 (Zn)
PDB code 6TBQ 6TC4 6TBR
Wavelength (Å) 1.30 0.98 1.04
Space group P212121 P212121 P1
a,b,c (Å) 46.31, 61.32, 72.98 46.72, 61.43, 73.78 46.06, 49.76, 57.10
Alpha, beta, gamma (°) 90, 90, 90 90, 90, 90 109.4, 90.1, 95.5
Resolution range (Å) 7.68-1.72 (1.76-1.72) 50.0-2.0 (2.05-2.00) 20.00-1.70 (1.74-1.70)
Completeness (%) 99.1(88.4) 97.5 (97.3) 92.6 (91.2)
R(meas) (%) 33.2 (232.7) 42.4 (238.6) 7.7 (45.5)
CC½(%) 98.7 (42.5) 92.2 (42.4) 99.4 (87.7)
Signal to noise [I/σ(I)] 4.6(0.6) 4.91 (1.87) 2.87 (9.04)
Total no. of reflections 36678 (2701) 59240 (4374) 81477 (5750)
No. of unique reflections 9725 (758) 14527 (1066) 48576 (3521)
R(work) (%) 22.05 18.52 19.17
R(free) (%) 26.33 22.25 24.64
No. of non-H atoms
Protein 1829 1817 1838/1870b
Metal ions 6 13 12
Water 163 179 533
Total 1998 2009 4253
Average B factor (Å2)
Protein 25.2 15.17 17.43/17.22b
Ion 47.7 52.59 20.40
Water 30.7 25.45 27.81
RMSD bond length (Å) 0.011 0.010 0.019
RMSD angles (°) 1.44 1.34 1.85
Ramachandran plot
Most favoured (%) 96.04 94.81 95.7
Allowed (%) 3.52 4.33 3.8
a Values for the outer shell is given in the parentheses. Dynarama in Coot [31] is used to generate the Ramachandran plot.
b Chain A/chain B.
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paper the metal ion exchange was validated by comparing 
the anomalous signal at either side of the zinc absorption 
edge.
We expected that if Zn was successfully exchanged 
for Cu we would see an increase of anomalous signal in 
the anomalous difference map in data collected at 1.35 Å 
wavelength compared to 1.00 Å wavelength for a copper 
site. Likewise, we will see a decrease for a Zn site, given 
the position of the edges for the two elements are 1.284 
Å for zinc and 1.381 Å for copper. Indeed the anomalous 
difference peak of the active-site metal increases from 
12.04σ in the 1.00 Å wavelength data to 33.20σ for the 
1.35 Å wavelength data, identifying it as copper, while an 
additional Zn binding site (between Glu125 and Asp129) 
shows a decrease from 5σ for the 1.0 Å data collection 
to less than 2σ for the 1.35 Å data collection. The signal 
corresponding to well-ordered sulphur atoms, for example 
the S in Cys25, is more or less the same (4σ) at both 
wavelengths. Small modifications of the metal exchange 
procedure still resulted in exchange for other crystals (data 
not shown). Unexpectedly, the reference un-exchanged 
structure shows a difference in conformation of the 
histidine brace compared to previously determined 
structures (discussed further below).
3.2  Low X-ray dose structure
The low X-ray dose structure received an average 
diffraction weighted dose of 2.57 kGy. This produced 
a data set with a partially photoreduced copper at the 
active site (Fig. 1A), where an equatorial water molecule is 
present 2.1 Å from the copper, but the axial water molecule 
is ejected completely. The B-factor for the equatorial 
water molecule is 36.3 Å2, while the B-factor for the rest 
of the active site is roughly 20 Å2. This indicates that not 
even the equatorial water molecule has full occupancy. 
The same crystal was afterwards exposed to 31.9 kGy 
(average diffraction weighted dose) and as visualized in 
Figure 1B, a clear difference is visible, as the equatorial 
water molecule is heavily depleted. For comparison, the 
best Zn-loaded structure (PDB code: 5T7J) in the same 
space group is shown in Figure 1C, while the previously 
published photoreduced Cu-loaded structure (PDB code: 
4OPB) is shown in Figure 1D.
3.3  Structure of glycosylated AoAA13 in P1 
space group
The structure of the glycosylated form of AoAA13 was 
solved in space group P1 to 1.7 Å resolution with two 
molecules in the asymmetric unit (Table 1), unlike the 
original structure, which was determined in space group 
P212121 with one molecule in the asymmetric unit. All 233 
amino acid residues were visible in the electron density, 
however, no glycosylation could be reliably modelled. 
In the structure of the glycosylated form of AoAA13 both 
molecules adopt the immunoglobin-like β-sandwhich fold 
(common of LPMOs) consisting of six β-strands as well as 
three short α-helices (Fig. 2) and are essentially identical 
(RMSD of 0.10 Å over Cα of all residues). In addition, the 
structure is very similar to the AoAA13 structure with 
active site Cu (PDB code: 4OPB) previously determined 
one in space group P212121 (RMSD of 0.42 and 0.43 Å over Cα 
of 232 residues for chain A and B, respectively) only with 
some minor variations in some loops (most pronounced in 
loop L6; Fig. 2B). The active site is ordered (in both chain 
A and B) and His1, His91, Tyr224 as well as two exogenous 
water ligands coordinate a Zn2+ ion in an octahedral 
arrangement (metal-ligand distances of 2.0-2.4 Å and 
angles ranging from 83-103°).
We have previously attempted to obtain 
oligosaccharide ligand complexes with the orthorhombic 
crystals, but found that the active site is partly occluded. 
The crystal contacts in the P1 space group lead to a less 
occluded presumed substrate binding site compared to 
the P212121 structure (especially compared to Zn-depleted 
structures; Fig. 3C middle) and thus were chosen for new 
oligosaccharide soaking experiments.
3.4  Serial synchrotron crystallography 
structure of AoAA13
The structure of AoAA13 could be determined by SSX 
through a mesh and collect procedure, and be refined 
to excellent R-factors and density (Fig. 4A) in the P212121 
space group. Surprisingly however, the (Zn-loaded) 
active site assumes a different conformation than seen 
previously (Fig. 4B). However, this conformation was also 
observed in a reference Zn structure used to demonstrate 
metal exchange, so it is not a consequence of the method, 
but could be a consequence of sample aging. In fact, it was 
noticed that crystals grown in this period were smaller 
than originally observed earlier in the project. However, 
and very puzzlingly, in the recrystallized P1 crystals also 
grown in this period (Table S1), the active site is in its 
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Figure 1: Structure of the active site in different structures of AoAA13. (A) The low dose, partly photoreduced Cu-loaded structure from this 
manuscript; (B) the same crystal exposed to a higher dose being fully photoreduced; (C) Zn-loaded structure (PDB code: 5T7J) [15]; (D) 
previous copper loaded structure (PDB code: 4OPB) [12] exhibiting a fully photoreduced copper ion. The maps are weighted 2Fo-Fc electron 
density maps contoured at the 1 σ level.
Figure 2: Chain A of the glycosylated form of AoAA13 in space group P1. Part (A) shows a side view, whereas part (B) shows a top view 
with marking of the flexible loops around the active site histidine brace. Loops separating secondary structure elements are numbered in 
accordance with their appearances in the sequence. Loops marked L3 (cyan), L6 (magenta) and L8 (orange) are equivalent to loop L3, LC and 
L8 in AA9 LPMOs ([1] and references therein), respectively, and correspond to the loop between β2 and β3, the long loop preceding β4, and 
the loop between β5 and β6 in [12]. In both (A) and (B) α-helices and β-strands are colored red and yellow, respectively.
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usual geometry (Fig. 4C). The average diffraction weighted 
dose received by the SSX structure is estimated to be 0.175 
kGy in Raddose3D, calculated based on the dose received 
by a single crystal.
3.5  Ligand binding experiments
We have previously attempted to obtain crystal 
complexes of AoAA13 in the orthorhombic crystal form 
by soaking crystals in different maltooligosaccharides 
with a degree of polymerization ranging between 2 and 
7 in Zn-depleted conditions and by cocrystallization 
(degree of polymerization 5). Thus initially, the rational 
for the metal exchange experiments was to stabilize the 
active site, as we had observed disorder in the previous 
oligosaccharide soaks in absence of Cu, which had been 
attributed to active-site metal depletion during the soaks. 
It was hypothesized that this induced small structural 
changes, which led to additional active-site occlusion 
in the crystal [15]. In the course of the present work we 
have observed, however, that some crystals where Zn has 
successfully exchanged with Cu nonetheless had a more 
occluded binding site. As such our previous conclusions 
seem incorrect and the slightly more or less open active 
site in the orthorhombic crystals does not have a simple 
explanation.
Soaking of a metal-exchanged orthorhombic crystal 
(open active site) with 0.5 M maltose did not result in 
complex formation (results not shown), which argues for 
the published complex with maltose (PDB code: 5LSV) [15] 
being primarily an artifact of crystal contacts. No other 
complexes could be obtained with this crystal form (see 
section 2.2).
Since the P1 crystal form is more open, it was used for 
additional ligand binding experiments with some of the 
Figure 3: Crystal packing and active site occlusion. (A) The active site in the P212121 space group, with distances to the closest symmetry 
related molecule. (B) The active site in the P1 space group with some distances to the closest symmetry related molecule. (C) Orthorhombic 
form of AoAA13 (grey). The AoAA13 after soak with maltose (green) in absence of Zn in shown in the middle, whereas the P1 structure of 
AoAA13 chain A and B (magenta) is shown on the right. Crystal contacts are shown in black and the histidine brace is shown in cyan.
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larger ligands. The P1 crystal form can be obtained from the 
glycosylated form of the AoAA13, or, by recrystallization, 
with the deglycosylated form of the protein. As the 
crystals of the glycosylated form have relatively high 
mosaicity (0.598°), we chose to use the recrystallized 
form (mosaicity of 0.162° for the reported data set; Table 
S1). β-Cyclodextrin as well as maltopentaose were tested 
(section 2.2) but no crystal complex could be obtained 
(results not shown).
In order to probe binding in solution, we used native 
differential scanning fluorimetry to test if several possible 
ligands showed sign of substrate-enzyme interactions by 
inducing a shift in melting temperature, but this was not 
the case with the ligands tested (see section 2.5) at the 
given concentrations.
3.6  Active-site conformations in crystals and 
in solution
A number of different conformations have been observed 
for the active-site histidines of AoAA13: (1) well-ordered, 
canonical LPMO active-site conformations; (2) the 
conformations in the disordered active sites in [15]; and 
(3) the conformation observed for the P212121 Zn-crystals in 
this study (Fig. 4C in red). As all structures of LPMOs with 
a highly occupied copper site show conformations similar 
to (1), we were curious to see if MD simulations in solution, 
upon removal of the copper, would show transition of the 
active sites to conformations similar to the disordered 
ones observed in (2) and (3). Thus we chose as the start of 
Figure 4: SSX structure. (A) Electron density in protein core; (B) electron density at histidine brace. (C) The histidine brace and supporting 
Tyr224. The previously published copper-loaded structure (PDB code: 4OPB), the most well-ordered Zn-loaded structure (PDB code: 5T7J), 
glycosylated AoAA13 in P1 (Zn-loaded, this manuscript), P1 recrystallization structure (Zn-loaded, this manuscript) are all depicted in blue, 
while the SSX structure (orthorhombic, this manuscript) and the reference Zn-AoAA13 (orthorhombic, this manuscript) are depicted in red.
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Figure 5: Forty ns MD simulations of AoAA13. (A) RMSD of side chains after superimposing Ca’s of all frames in simulation compared to the 
first frame of the simulation. Residues above an RMSD of 0.25 Å are listed in Table S3. Residue Phe166 is indicated with a black arrow. 
(B) Average coordinate RMSD throughout each 40 ns simulation. In order to identify steps in the MD simulation reproducing the disorder 
seen in the crystal structures, RMSD of His91 was calculated against that of the AoAA13-Hisflip structure (PDB code: 5T7K) published in 
[15] (C), while RMSD of the N-terminal histidine against that of the SSX structure (D) using Biopython [34]. (E) and (F) They show selected 
conformations of interest in simulations 1 and 2, respectively, as mentioned in the text. The His91 conformations shown in (F) are 
representative of all conformations adopted throughout simulation 2, as reflected in (C). (G) and (H) They show the general conformation of 
Phe166 (indicated with black arrow) in both simulations, respectively. Simulation 1 is shown in red, simulation 2 in blue, the structure with 
the PDB code 5T7K in tan, and the SSX structure in green.
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our simulation the well-ordered Cu-loaded structure (PDB 
code: 4OPB) after stripping it of the metal ion.
Figures 5A and 5B show the side chain RMSD from 
starting structure per residue (over a 40 ns simulation), 
and for the whole protein over time, respectively. Loop 
L6 (refer to Figure 2 for notation) containing Phe166 
was particularly mobile, much more so than the regions 
containing the active-site histidines. In simulation 1 
(Fig. 5G) Phe166 flips quickly to an outward position and 
remains solvent exposed for the rest of the simulation. 
In simulation 2 after equilibration Phe166 packs against 
a loop, but is still very distant from the active site (Fig. 
5H). While Phe166 has been modelled in alternate and 
somewhat different conformations in the various crystal 
structures, none of these conformations are so distant 
from the active site. The two active-site histidines show 
mobility in the MD simulations, but not to the same extent 
(Fig. 5A,C,D). In particular, the large His91 ‘flip’, which is 
observed in the published structure with PDB entry 5T7K 
[15], is mostly not observed in either simulations (Fig. 5C), 
though some conformations are close (e.g., at 19.0 ns in 
simulation 1; Fig. 5E). We interpret this as a consequence 
of the mobility of the L6 loop bearing Phe166 in solution, 
moving this residue further away from the active site 
and thus diminishing the possibility for the stabilizing 
interaction with a ‘flipped’ His91 side chain as seen in 
the 5T7K crystal structure. Instead, His91 tended to bury 
itself and seemingly interact with other residues from the 
L3 loop and Tyr224 (Fig. 5E at 23.1, 38.7 and 38.38 ns), or 
position itself in between the usual conformation and the 
‘flipped’ conformation (Fig. 5F). His1 also tended to move 
towards the position normally occupied by the metal ion 
(e.g., Fig. 5E at 38.8 ns), furthermore the imidazole group 
often flipped 90° resembling somewhat the conformation 
observed in the SSX structure and the reference Zn-AoAA13 
structure in this work (e.g., Fig. 5E at 38.7 ns).
4  Discussion and conclusions
In this study we present a successful and verified 
procedure for exchanging the active-site metal from Zn to 
Cu in orthorhombic crystals of AoAA13, which has been 
used for further studies.
A number of structures of AoAA13 have been previously 
presented, mostly with Zn at the active site, as for example 
PDB code: 5T7J, which presents a well-ordered active site. 
In the only copper-loaded structure available (PDB code: 
4OPB), the copper is presumably photoreduced to Cu(I). 
It is likely that the geometry around the Zn represents a 
Cu(II) state quite closely. On the other hand, several of the 
Zn-loaded structures we presented in the past show some 
disorder of the active site.
Thus we sought to obtain a low dose X-ray crystal 
structure of AoAA13, as previously obtained for other 
AA9 and AA10 LPMOs [36-38]. The structure presented 
here obtained by limiting the dose by beam attenuation, 
short exposures and helical data collection shows a 
partly photoreduced active site, with clear density for 
the equatorial ligand. The average diffraction weighted 
dose received was 2.57 kGy for this data set, while a dose 
of 31.9 kGy is sufficient for full photoreduction. It is not 
easy to compare this dose directly to the doses reported 
for EfAA10A crystals, since an earlier version of RADDOSE 
was used. It is, however, likely that the doses reported by 
Gudmundsson et al. [36] are either the maximum dose or 
the average dose for the exposed volume, which for the 
low/higher dose AoAA13 structures presented here are 
5.67/5.07 kGy and 70.2/62.9 kGy, respectively. For the least 
photoreduced structure of EfAA10A (PDB code: 4ALC) the 
dose is reported as 82.7 kGy, which corresponds well to 
a Cu(II) form. Thus at much lower doses than adequate 
to maintain a Cu(II) state for EfAA10A, AoAA13 is clearly 
photoreduced. For LsAA9A, a fully photoreduced 
structure has never been obtained. This clearly indicates 
that AoAA13 is much more susceptible to photoreduction 
than other LPMOs, which perhaps can be correlated to 
its unusual electron paramagnetic resonance spectrum, 
where hyperfine coupling is visible in the absence of 
oligosaccharide ligands, unlike other LPMOs [12].
The geometries at the active site for well-ordered 
Zn-loaded structures, low dose structure and Cu(I) 
structure are shown in Table S2. The distances to histidine 
ligands are typical of other LPMOs. The Tyr-metal 
distances are somewhat shorter for the well-ordered 
Zn-loaded structures than the Cu-loaded structures, while 
the distance to the water ligands slightly longer than to 
the partly photoreduced Cu-loaded structure. In terms of 
θ1, θ2 and θ3, the well-ordered Zn structures are closer to 
the Cu(II) geometry, while both Cu-structures are closer to 
Cu(I) geometry [2].
We additionally determined a (Zn-loaded) structure 
by SSX to see if the approach could eventually be used 
for obtaining a Cu(II) structure, since in this method only 
few degrees are collected on each of many small crystals. 
Since the dose can be reduced by at least one order of 
magnitude, and the structure has a reasonable quality, 
the SSX approach could be attempted in the future after 
metal exchange. Perhaps together with the use of very 
short wavelengths, a Cu(II) structure of AoAA13 can be 
obtained in this way.
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This study presents also the structure of a glycosylated 
AoAA13 structure crystallized in the P1 space group with 
two molecules in the asymmetric unit, with a well-ordered 
Zn containing active site. This P1 crystal form could be 
obtained by recrystallization in drops containing already 
formed orthorhombic crystals. Several ligand binding 
experiments were conducted in the crystals, in both 
orthorhombic and triclinic crystal form, but no crystal 
structure with substrate ligand bound was obtained, even 
though the putative substrate binding groove is much 
more open in the P1 structure.
In addition, no shift of thermal inflection point 
was observed in solution with several putative ligands, 
providing no additional evidence that AoAA13 binds 
soluble substrates. It should be noted that lack of 
binding cannot be alone concluded by the thermal shift 
experiments as substrate binding does not guarantee 
a change in inflection point. Activity has not been 
demonstrated for this particular LPMO, but the presumed 
binding surface near the active site is highly conserved 
in this family (Fig S1; sequences analyzed with the 
ConSurf server [39]). In the last stages of completion of 
this manuscript, a detailed study of substrate preference 
of two AA13 LPMOs, one naturally with and one without 
CBM, has been published [40]. Based on the pattern 
of degradation and computational docking using the 
structure of AoAA13 (the only one still available for this 
family), the authors suggest that maltooctaose may be 
the minimal substrate and furthermore suggest that 
the preferred substrate is an amylose double helix. 
Absence of CBM considerably reduced binding. Lack 
of CBM in AoAA13, as well as the fact that the putative 
ligands tested here are smaller than the suggested 
minimal length, could provide an explanation for our 
negative crystallographic and thermal shift assay results. 
Furthermore, as more LPMO-like proteins are identified 
with low or non-detectable polysaccharide degradation 
activity [41], and since AA13 oxidative activity on starch 
has been also notoriously difficult to detect, it could be 
that the family AA13 members, though clearly linked 
to starch degradation as elegantly demonstrated by 
proteomic studies in A. niger [42], may have other primary 
functions than just biomass breakdown.
The SSX structure turned out to have a different 
geometry of the active site, which was the same as in the 
Zn-loaded orthorhombic structure used as reference for 
metal exchange, but very puzzlingly, different from the 
structure of the same sample after recrystallization in P1 
space group. For the distorted SSX Zn site, the distance 
to the tyrosine ligand is also unusually short. Apart from 
already discussed consequences as possible result of 
sample aging [15] and consequences for storage of LPMOs, 
this is an additional example of active-site plasticity.
In order to further probe this plasticity, MD simulations 
were conducted with a metal deprived structure. This was 
done to see if conformations observed in the crystal could 
be observed in the simulations, especially an extreme ‘flip’ 
of His91, one of the histidine brace histidines. Surprisingly, 
while we did not observe a flip of His91 during most of the 
simulation, we observed instead that Phe166, with which 
the ‘flipped’ His91 interacts in crystal structures, is flipped 
quickly out of its usual position in the crystal structures 
(Fig. 5G,H). According to the simulations, Phe166 sits in 
a very flexible loop between β-strand 3 and 4 (loop L6; 
Fig. 2B), and after 10 ns both this loop and the adjacent 
loop bearing His91 (loop L3; Fig. 2B) have considerably 
different conformation than in the crystal structures. 
Loop L3 has identical conformations in all AA13 crystal 
structures determined, because its movement is restricted 
by crystal contacts. Because loop L3 packs against loop 
L6, it also is restricted in the crystal structure. In contrast 
the loop separating β-strand 5 and 6 (loop L8 in Figure 2B, 
previously denoted loop β5-β6 in [12]) clearly shows high 
variability in the crystal structures.
Since Phe166 cannot flip out away from the active 
site in the crystal, alternative motions are observed in the 
crystal in response to loss of metal binding. Interestingly, 
Phe166 marks the beginning of the ‘variable substrate 
interaction region’ in the most recent article on AA13 [40], 
which almost perfectly coincides with the most flexible 
part of the structure in both simulations (residues 166-
170) and thus these dynamics are likely to be of functional 
importance. A recent study of dynamics of LPMOs [43] 
by the computationally cheaper Elastic Network Model 
method, identified two different regions of correlated 
dynamics in AoAA13 (residues 206-213 and 213-221). The 
differences may be due to the different timescales probed 
by the different methods.
In conclusion, this paper presents advances in the 
methodology for detailed structural analysis of the starch-
active family of LPMOs, AA13, and in the understanding of 
how their dynamics may affect their function.
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